Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Telus Corporation Ordinary Shares (TU) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Telus Corporation Ordinary SharesTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Telus Corporation Ordinary Shares vs State Street SPDR S&P Biotech ETF — how do they compare? Telus Corporation Ordinary Shares trades at $8.11 (market cap $12.52B), while State Street SPDR S&P Biotech ETF trades at $147.02 (market cap $10.27B). The key difference: Telus Corporation Ordinary Shares is the larger of the two by market cap, and Telus Corporation Ordinary Shares pays a 6.59% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Telus Corporation Ordinary Shares for 0 Days and State Street SPDR S&P Biotech ETF for 39 Days on average.

TUXBI
Market Cap
$12.52B$10.27B
Volume
6,655,0349,751,587
Sector
MediaBroad Market / Factor
52-Week High
$15.33$169.55
52-Week Low
$7.72$107.32
Typical Hold Time
0 Days39 Days
Enterprise Value
$33.57B—
Dividend Yield
6.59%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Telus Corporation Ordinary Shares

No Aura AI signal available yet.

State Street SPDR S&P Biotech ETF

XBI trades at $146.8, down 3.04% today, with a bearish technical signal driven by selling pressure in moving averages. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts. Recent news highlights sector optimism from cancer vaccine breakthroughs and improved capital access, though the ETF carries higher volatility than diversified healthcare funds.

Outlook remains mixed with neutral analyst consensus but positive sector catalysts. Opportunities include biotech innovation and M&A potential, while risks involve high volatility, regulatory uncertainty, and expense ratios above broader healthcare ETFs. Investors should weigh targeted biotech exposure against sector-wide stability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TU
100% Buy0% Sell
Avg holding period · 0 Days
XBI
100% Buy0% Sell
Avg holding period · 39 Days

About Telus Corporation Ordinary Shares

Telus Corporation is a Canadian telecommunications company providing wireless, internet, television, and business connectivity services, with additional operations in digital healthcare through Telus Health and customer experience services through Telus Digital.

Read more on TU →

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI →